Delayed ABLC prophylaxis after allogeneic stem-cell transplantation

Mycoses

Volumn 49, Issue 5, 2006, Pages 397-404

  Jansen, Jan ^a   Akard, Luke P ^a   Wack, Matthew F ^b   Thompson, James M ^a   Dugan, Michael J ^a   Leslie, Jill K ^a,c   Mattison, Reid ^b  

^a Indiana Blood and Marrow Transplantation   (United States)

^b Infectious Diseases of Indiana   (United States)

^c St Francis Hospital & Health Centers   (United States)

Author keywords

Allogeneic stem cell transplantation; Amphotericin B lipid complex; Corticosteroids; Fungal infection; Graft versus host disease

Indexed keywords

ALEMTUZUMAB; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; CORTICOSTEROID; FLUCONAZOLE; ITRACONAZOLE; PYRROLE DERIVATIVE; THYMOCYTE ANTIBODY; VORICONAZOLE;

ADOLESCENT; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLOSIS; CANDIDIASIS; CHEMOPROPHYLAXIS; DELAYED DIAGNOSIS; EARLY DIAGNOSIS; FEMALE; GRAFT VERSUS HOST REACTION; HIGH RISK PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOSIS; OPEN STUDY; PILOT STUDY; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; STEROID THERAPY; TRICHOSPORON BEIGELII;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AMPHOTERICIN B; ANTI-INFLAMMATORY AGENTS; ANTIFUNGAL AGENTS; CHILD; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYCOSES; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLGLYCEROLS; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; PREDNISONE; STEM CELL TRANSPLANTATION; STEROIDS; TIME FACTORS; TREATMENT OUTCOME;

TRICHOSPORON BEIGELII;

EID: 33747074875     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2006.01264.x     Document Type: Article

References (22)

1. Wingard JR. Fungal infections after bone marrow transplant. Biol Blood Marrow Transplant 1999; 5: 55-68.
2. Jamunen E, Anttila V-J, Ruutu T. Aspergillus infections in allogeneic stem cell transplant recipients: have we made any progress? Bone Marrow Transplant 2002; 30: 925-9.
3. Martino R, Subira M, Rovira M et al. Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients. Br J Haematol 2002; 116: 475-82.
4. Fukuda T, Boeckh M, Carter RA et al. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood 2003; 102: 827-33.
5. Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002; 100: 4358-66.
6. Mehta J, Kelsey S, Chu P et al. Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignancies. Bone Marrow Transplant 1997; 20: 39-43.
7. Walsh TJ, Pappas P, Winston DJ et al. Voriconazole compared with liposomal amphotericin-B for empirical antifungal therapy in patients with neutropenia and persistent fever. New Engl J Med 2002; 346: 225-34.
8. Rousey SR, Russler S, Gottlieb M, Ash RC. Low-dose amphotericin-B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation. Am J Med 1991; 91: 484-92.
9. Goodman JL, Winston DJ, Greenfield RA et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. New Engl J Med 1992; 326: 845-51.
10. O'Donnell MR, Schmidt GM, Tegtmeier BR et al. Prediction of systemic fungal infection in allogeneic marrow recipients; impact of amphotericin prophylaxis in high-risk patients. J Clin Oncol 1994; 12: 827-34.
11. Ascioglu S, Rex JH, De Pauw B et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infet Dis 2002; 34: 7-14.
12. McGlave P, Bartsch G, Anasetti C et al. Unrelated donor marrow transplantation for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program. Blood 1993; 81: 543-50.
13. Adedoyin A, Bernardo JF, Swenson CE et al. Pharmacokinetic profile of Abelcet (Amphotericin B lipid complex injection): combined experience from phase I and phase II studies. Antimicrobl Agents Chemother 1997; 41: 2201-8.
14. Tollemar J, Ringdén O, Andersson S, Sundberg B, Ljungman P, Tyden G. Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients. Bone Marrow Transplant 1993; 12: 577-82.
15. CDS/IDSA/ASBMT. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Recommendations of CDC,the Infectious Diseases Society of America and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2000; 6: 659-728.
16. Slavin MA, Osborne B, Adams R et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation - a prospective, randomized, double-blind study. J Infect Dis 1995; 171: 1545-52.
17. Marr KA, Seidel K, Slavin MA et al. Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized placebo-controlled trial. Blood 2000; 96: 2055-61.
18. Winston DJ, Maziarz RT, Chandrasekar PH et al. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. Ann Intern Med 2003; 138: 705-13.
19. Marr KA, Crippa F, Leisenring W et al. Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants. Blood 2004; 103: 1527-33.
20. Blood and Marrow Transplant Clinical Trials Network. Protocol 0101: A Randomized Double-blind Trial of Fluconazole and Voriconazole for the Prevention of Invasive Fungal Infections in Allogeneic Marrow Transplant Recipients. http://spitfire.emmes.com/study/bmt
21. VanBurik JAH, Ratanatharathorn V, Stepan DE et al. Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation. Clin Infect Dis 2004; 39: 1407-16.
22. Marty FM, Cosimi LA, Baden LR. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplant. New Engl J Med 2004; 350: 950-2.